Clinical Trial: Apixaban for Prevention of Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection: One-Year and Long-Term Follow-Up Study

U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07461532) titled 'Apixaban for Prevention of Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection: One-Year and Long-Term Follow-Up Study' on March 04.

Brief Summary: The purpose of this study is to determine whether Apixaban is effective and safe in the prevention of portal vein thrombosis at one year and long-term follow-up in liver cirrhotic patients after laparoscopic splenectomy and azygoportal disconnection

Study Start Date: March 04, 2025

Study Type: INTERVENTIONAL

Condition: Cirrhosis Splenectomy Venous Thrombosis Hypertension, Portal

Intervention: DRUG: Apixaban 2.5 MG

From postoperative day 3, Patients...